Mark Toshner Selected Research

Fever (Fevers)

10/2021	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
1/2021	Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Toshner Research Topics

Disease

18	Pulmonary Hypertension 01/2024 - 11/2007
15	Pulmonary Arterial Hypertension 03/2024 - 11/2010
7	Familial Primary Pulmonary Hypertension 01/2023 - 02/2011
7	COVID-19 01/2023 - 01/2021
4	Thrombosis (Thrombus) 07/2023 - 01/2014
3	Dyspnea (Shortness of Breath) 01/2023 - 01/2021
2	Inflammation (Inflammations) 03/2023 - 01/2019
2	Pulmonary Embolism 03/2023 - 01/2019
2	Hypoxia (Hypoxemia) 03/2022 - 01/2016
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Cough 10/2021 - 01/2021
2	Anosmia 10/2021 - 01/2021
2	Fever (Fevers) 10/2021 - 01/2021
2	Heart Failure 11/2014 - 04/2011
1	Lung Diseases (Lung Disease) 01/2023
1	Acute Coronary Syndrome 01/2023
1	Hemorrhage 01/2023
1	Virus Diseases (Viral Diseases) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Viral Pneumonia 01/2022
1	Infections 10/2021
1	Heart Diseases (Heart Disease) 10/2020
1	Sarcoidosis (Schaumann Disease) 10/2020
1	Pulmonary Sarcoidosis 10/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020
1	Disease Susceptibility (Diathesis) 01/2020
1	Gastroparesis 04/2019
1	Starvation 04/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Channelopathies 10/2018
1	Castleman Disease (Castleman's Disease) 01/2018
1	Rheumatoid Arthritis 01/2018
1	Mixed Connective Tissue Disease (MCTD) 01/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018
1	Rare Diseases (Rare Disease) 11/2017
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 11/2017
1	Lymphadenopathy 11/2017
1	Vascular Remodeling 01/2016
1	Disease Progression 12/2014

Drug/Important Bio-Agent (IBA)

4	Interleukin-6 (Interleukin 6)IBA 03/2024 - 01/2018
4	CamphorIBA 10/2021 - 01/2020
3	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 11/2007
3	Nucleic AcidsIBA 10/2021 - 01/2021
3	VaccinesIBA 10/2021 - 01/2021
3	ChAdOx1 nCoV-19IBA 10/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 03/2022 - 04/2019
2	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2011
2	ProteomeIBA 01/2022 - 01/2022
2	Imatinib Mesylate (Gleevec)FDA Link 10/2021 - 11/2010
2	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 10/2016
1	Cathepsin ZIBA 01/2024
1	selexipagIBA 01/2024
1	riociguatIBA 01/2024
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 07/2023
1	Angiopoietin-2IBA 01/2023
1	Factor V (Coagulation Factor V)IBA 03/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	MenACWYIBA 10/2021
1	Blood Proteins (Serum Proteins)IBA 10/2020
1	Sildenafil Citrate (Viagra)FDA Link 10/2020
1	Bosentan (Tracleer)FDA Link 10/2020
1	GadoliniumIBA 10/2020
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 10/2020
1	Iloprost (Ventavis)FDA Link 10/2020
1	AnticoagulantsIBA 01/2020
1	Natriuretic PeptidesIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2019
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2019
1	AntigensIBA 01/2019
1	Anti-Arrhythmia AgentsIBA 01/2019
1	N 30IBA 01/2019
1	PotassiumIBA 10/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	tocilizumab (atlizumab)FDA Link 01/2018
1	Calcium Channels (Calcium Channel)IBA 12/2017
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2017
1	Carbon MonoxideIBA 11/2017
1	Prokaryotic Initiation Factor-2IBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	Peroxidase (Myeloperoxidase)IBA 10/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 10/2016
1	ArginaseIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 10/2015
1	LipopolysaccharidesIBA 10/2015
1	Endothelin Receptors (Endothelin Receptor)IBA 11/2014
1	Endothelin-1 (Endothelin 1)IBA 11/2014
1	erucylphosphocholineIBA 12/2012

Therapy/Procedure

12	Endarterectomy (Thromboendarterectomy) 07/2023 - 11/2007
8	Therapeutics 01/2024 - 11/2010
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2023
1	Length of Stay 01/2023
1	Extracorporeal Membrane Oxygenation 01/2022
1	Catheters 04/2019
1	Central Venous Catheters 04/2019
1	Electric Countershock (Cardioversion) 01/2019
1	Immunomodulation 01/2018
1	Perioperative Period 05/2016